Transplant drug can boost immune responseJune 22nd, 2009 - 4:39 pm ICT by ANI
London, June 22 (ANI): Scientists at the Emory Vaccine Centre have discovered that a transplant drug called rapamycin can stimulate immune memory, which enables the immune system to respond faster and stronger to an infectious agent.
The study showed that rapamycin, given to transplant patients to suppress their immune system, can trigger the formation of memory CD8 T cells, enabling the immune system to respond faster upon secondary encounter.
Postdoctoral researcher Koichi Araki says that the new discovery will help improve the efficacy of vaccines with drugs that act similarly to rapamycin.
“Usually during the response to this virus, 90 percent of the CD8 T cells produced to fight an infection die after a few weeks,” Nature magazine quoted Araki as saying.
“The memory cells are generated from the 10 percent that survive,” he added.
The study showed that when mice infected with lymphocytic choriomeningitis virus (LCMV) were treated with rapamycin, more CD8 T survived.
Rapamycin’s effects are “surprising and unexpected,” said Araki.
For transplant patients, memory T cells can play a role in graft rejection, but they can also protect against infections. (ANI)
- 'Pep talk' can revive exhausted immune cells: Study - Dec 14, 2011
- Original HIV infection holds its sway despite numerous changes - Jun 30, 2010
- Trapping WBC may be a novel strategy against chronic viral infections - Aug 14, 2008
- Early immune response may help combat hit-and-hide cancer viruses - Jan 16, 2010
- New vaccine technology shows promise against hepatitis C virus - Feb 24, 2011
- How HIV escapes treatment - Mar 08, 2010
- Bioengineered protein may help fight leukemia - Feb 19, 2011
- Stem cells can be engineered to kill HIV - Dec 09, 2009
- The reason behind mildness of 2009 H1N1 pandemic - Jun 19, 2010
- Scientists tame HIV by stripping it of cholesterol - Sep 29, 2011
- H1N1 pandemic flu strain 'key to universal vaccine' - Jan 11, 2011
- New discovery may help boost effectiveness of human vaccines - Jan 28, 2010
- Discovery could lead to 'next-gen' vaccines - Apr 08, 2012
- Unexpected find may lead to novel ways to stop HIV - Jan 24, 2011
- Researchers keep hepatitis C at bay after liver transplant - Jan 01, 2010
Tags: araki, cd8 t cells, efficacy, emory, encounter, graft rejection, immune memory, immune response, immune system, infectious agent, lcmv, memory cells, mice, nature magazine, new discovery, rapamycin, researcher, scientists, vaccines, virus